Vídeo

By finabiotech|2021-06-03T09:25:04+01:00junio 3rd, 2021|Finabiotech News|

Success story between UAM and FinaBiotech

Comentarios desactivados

“There is a real and proven demand among urologists to develop a non-invasive method for monitoring bladder cancer patients”

Elena Arochena, Executive Director

“Only a urine sample from the patient is enough to diagnose bladder cancer. RT-PCR technology allows us to measure the genetic expression and give us quantitative results”

Daniel Bermejo, Clinical Development and Patents Manager

“Signatures of 2, 5, 10 and 12 genes have been identified. They all display strong diagnostic performance”

Dra. Lourdes Mengual, Clinic Hospital